Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigía Group, 1993 to 1999. PAHO Sireva-Vigía Study Group. Pan American Health Organization

dc.creatorDi Fabio, J L
dc.creatorCastañeda, E
dc.creatorAgudelo, Clara Inés
dc.creatorDe La Hoz, F
dc.creatorHortal, M
dc.creatorCamou, T
dc.creatorEchániz-Avilés, G
dc.creatorCarnalla Barajas, M N
dc.creatorHeitmann, I
dc.creatorHormazabal, J C
dc.creatorBrandileone, M C
dc.creatorDias Vieira, V S
dc.creatorRegueira, Mabel
dc.creatorRuvinsky, R O
dc.creatorCorso, Alejandra
dc.creatorLovgren, M
dc.creatorTalbot, J A
dc.creatorDe Quadros, C
dc.date2020-12-14T19:42:15Z
dc.date2020-12-14T19:42:15Z
dc.date2001-10
dc.date.accessioned2023-08-29T20:07:49Z
dc.date.available2023-08-29T20:07:49Z
dc.identifier0891-3668
dc.identifierhttp://sgc.anlis.gob.ar/handle/123456789/1898
dc.identifier10.1097/00006454-200110000-00009
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8519857
dc.descriptionFil: Di Fabio, José Luis. Pan American Health Organization. Division of Vaccines and Immunization; Estados Unidos.
dc.descriptionFil: Castañeda, Elizabeth. Instituto Nacional de Salud; Colombia.
dc.descriptionFil: Agudelo, Clara Inés. Instituto Nacional de Salud; Colombia.
dc.descriptionFil: De La Hoz, Fernando. Universidad Nacional de Colombia. Facultad de Medicina. Departamento de Salud Pública. Instituto de Salud Pública; Colombia.
dc.descriptionFil: Hortal, María. Departamento de Laboratorios de Salud Pública; Uruguay.
dc.descriptionFil: Camou, Teresa. Departamento de Laboratorios de Salud Pública; Uruguay.
dc.descriptionFil: Echániz-Avilés, Gabriela. Instituto Nacional de Salud Pública; México.
dc.descriptionFil: Barajas, María Noemi Carnalla. Instituto Nacional de Salud Pública; México.
dc.descriptionFil: Heitmann, Ingrid. Instituto de Salud Pública, Chile.
dc.descriptionFil: Hormazabal, Juan Carlos. Instituto de Salud Pública, Chile.
dc.descriptionFil: Brandileone, María Cristina C. Instituto Adolfo Lutz; Brasil.
dc.descriptionFil: Dias Vieira, Vera Simonsen. Instituto Adolfo Lutz; Brasil.
dc.descriptionFil: Regueira, Mabel. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
dc.descriptionFil: Ruvinski, Raúl. Hospital Municipal M. Durand; Argentina.
dc.descriptionFil: Corso, Alejandra. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.
dc.descriptionFil: Lovgren, Marguerite. National Centre for Streptococcus; Canadá.
dc.descriptionFil: Talbot, James A. National Centre for Streptococcus; Canadá.
dc.descriptionFil: De Quadros, Ciro. Pan American Health Organization. Division of Vaccines and Immunization; Estados Unidos.
dc.descriptionBackground: Since 1993 the Pan American Health Organization has coordinated a surveillance network with the National Reference Laboratories of Argentina, Brazil, Chile, Colombia, Mexico and Uruguay aimed at monitoring capsular types and antimicrobial susceptibility of Streptococcus pneumoniae causing invasive disease in children <6 years of age. Methods: The surveillance system included children 6 years of age and younger with invasive disease caused by S. pneumoniae. The identification, capsular typing and susceptibility to penicillin of the isolates were conducted using a common protocol, based on standard methodologies. Results: By June, 1999, 4,105 invasive pneumococcal isolates had been collected mainly from pneumonia (44.1%) and meningitis (41.1%) cases. Thirteen capsular types accounting for 86.1% of the isolates (14, 6A/6B, 5, 1, 23F, 19F, 18C, 19A, 9V, 7F, 3, 9N and 4) remained the most common types during the surveillance period. Diminished susceptibility to penicillin was detected in 28.6% of the isolates, 17.3% with intermediate and 11.3% with high level resistance. Resistance varied among countries and increased during this period in Argentina, Colombia and Uruguay. Serotypes 14 and 23F accounted for 66.6% of the resistance. Conclusion: These surveillance data clearly demonstrate the potential impact of the introduction of a conjugate vaccine on pneumococcal disease and the need for more judicious use of antibiotics to slow or reverse the development of antimicrobial resistance.
dc.languageen
dc.publisherLippincott, Williams & Wilkins
dc.publisherPediatric Infectious Diseases Society
dc.publisherEuropean Society for Paediatric Infectious Diseases
dc.relation#PLACEHOLDER_PARENT_METADATA_VALUE#
dc.relationdatasets
dc.relationThe Pediatric infectious disease journal
dc.rightsnone
dc.sourcePediatric Infectious Disease Journal 2001; 20(10):959-67
dc.subjectNiño
dc.subjectPreescolar
dc.subjectFemenino
dc.subjectHumanos
dc.subjectLactante
dc.subjectModelos Logísticos
dc.subjectMasculino
dc.subjectMéxico
dc.subjectPenicilinas
dc.subjectInfecciones Neumocócicas
dc.subjectVigilancia de la Población
dc.subjectGarantía de la Calidad de Atención de Salud
dc.subjectControl de Calidad
dc.subjectSerotipificación
dc.subjectAmérica del Sur
dc.subjectStreptococcus pneumoniae
dc.subjectResistencia a las Penicilinas
dc.titleEvolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigía Group, 1993 to 1999. PAHO Sireva-Vigía Study Group. Pan American Health Organization
dc.typeArtículo


Este ítem pertenece a la siguiente institución